• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:LI

65.090 EUR 1.200 1.81%

As of 09:03:14 ET on 10/24/2014.

Snapshot for UCB SA (UCB)

Open: 66.450 Day's Range: 64.170 - 66.500 Volume: 49,239
Previous Close: 66.290 52wk Range: 45.870 - 75.800 1-Yr Rtn: +39.22%

Stock Chart for UCB

No chart data available.
  • UCB:LI 65.085
  • 1D
  • 1M
  • 1Y
66.290
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 31.1213
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.0780
Est. PEG Ratio 1.8552
Market Cap (M EUR) 12,578.68
Shares Outstanding (M) 194.51
30 Day Average Volume 8,396
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.61%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Roch F DoliveuxCo-Chief Executive OfficerJean-Christophe TellierExec VP:Biopharma/CEO-Elect
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil